NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 816 filers reported holding NOVARTIS A G in Q4 2013. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $12,000 | -87.0% | 165 | -85.8% | 0.00% | -87.5% |
| Q3 2016 | $92,000 | -4.2% | 1,165 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $96,000 | +14.3% | 1,165 | 0.0% | 0.01% | +14.3% |
| Q1 2016 | $84,000 | -16.0% | 1,165 | 0.0% | 0.01% | -12.5% |
| Q4 2015 | $100,000 | -6.5% | 1,165 | 0.0% | 0.01% | -20.0% |
| Q3 2015 | $107,000 | -7.0% | 1,165 | 0.0% | 0.01% | +11.1% |
| Q2 2015 | $115,000 | 0.0% | 1,165 | 0.0% | 0.01% | +12.5% |
| Q1 2015 | $115,000 | +6.5% | 1,165 | 0.0% | 0.01% | +14.3% |
| Q4 2014 | $108,000 | -1.8% | 1,165 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $110,000 | +4.8% | 1,165 | 0.0% | 0.01% | +16.7% |
| Q2 2014 | $105,000 | +6.1% | 1,165 | 0.0% | 0.01% | +20.0% |
| Q1 2014 | $99,000 | +5.3% | 1,165 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $94,000 | +59.3% | 1,165 | +52.3% | 0.01% | +66.7% |
| Q3 2013 | $59,000 | +9.3% | 765 | 0.0% | 0.00% | -25.0% |
| Q2 2013 | $54,000 | – | 765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |